Collectively, these findings again suggest that the protein levels of EGFR correlate very well with the responsiveness of GC cell lines to ganetespib treatment and have a critical role in sensitizing GC cell lines to ganetespib treatment. This evidence concerns the gene EGFR and gastric cancer.